SEC Filing Summary for Marc Cobo - BridgeBio Oncology Therapeutics, Inc.

This SEC filing details a transaction by Marc Cobo, Principal Accounting Officer at BridgeBio Oncology Therapeutics, Inc. On July 1, 2026, Mr. Cobo disposed of 125 shares of Common Stock at a price of $7.8 per share. This transaction was made to cover tax withholding obligations in connection with the vesting of restricted stock units. Following this transaction, Mr. Cobo owns 5306 shares of the company's Common Stock. The filing is Form 4, indicating a change in beneficial ownership.